2-(2-Hydroxyethyl)pyridine

CAS No. 103-74-2

2-(2-Hydroxyethyl)pyridine( —— )

Catalog No. M10186 CAS No. 103-74-2

2-Pyridineethanol is used as an intermediate in industry.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 43 In Stock
100MG 56 In Stock
200MG Get Quote In Stock
500MG 128 In Stock
1G 184 In Stock

Biological Information

  • Product Name
    2-(2-Hydroxyethyl)pyridine
  • Note
    Research use only, not for human use.
  • Brief Description
    2-Pyridineethanol is used as an intermediate in industry.
  • Description
    2-Pyridineethanol is used as an intermediate in industry.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    103-74-2
  • Formula Weight
    123.15
  • Molecular Formula
    C7H9NO
  • Purity
    >98% (HPLC)
  • Solubility
    soluble in Ethanol
  • SMILES
    OCCC1=CC=CC=N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Icsel C, et al. Eur J Med Chem. 2013 Feb;60:386-94.
molnova catalog
related products
  • Fructo-oligosacchari...

    Fructo-oligosaccharide DP10/GF9 belongs to fructooligosaccharides (FOS) with degree of polymerization (DP=10). Fructo-oligosaccharides (FOS) are composed of 9 fructose units linked by (2→1)-β-glycosidic bonds and having a single D-glucosyl unit at the non-reducing end.

  • N106

    N106 directly activates the SUMO-activating enzyme, E1 ligase, and triggers intrinsic SUMOylation of SERCA2a.

  • Compound 35

    Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses.Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses. Compounds 35 have shown good metabolic stability in plasma and liver microsomes (rat and human), and 32 did not inhibit CYP3A4 nor CYP2C9.